A detailed history of E Fund Management Co., Ltd. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 1,874 shares of CRL stock, worth $318,767. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,874
Previous 1,853 1.13%
Holding current value
$318,767
Previous $278,000 2.16%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$99.75 - $151.89 $2,094 - $3,189
21 Added 1.13%
1,874 $284,000
Q1 2025

May 12, 2025

BUY
$150.52 - $190.14 $4,967 - $6,274
33 Added 1.81%
1,853 $278,000
Q4 2024

Feb 06, 2025

BUY
$178.58 - $220.69 $325,015 - $401,655
1,820 New
1,820 $335,000
Q1 2024

May 13, 2024

BUY
$203.52 - $273.43 $150,401 - $202,064
739 New
739 $200,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.65B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track E Fund Management Co., Ltd. Portfolio

Follow E Fund Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management Co., Ltd. with notifications on news.